Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes

Eman Alfadhli, Eman Osman, Taghreed Basri, Eman Alfadhli, Eman Osman, Taghreed Basri

Abstract

Background: Women with gestational diabetes mellitus (GDM) are required to control their blood glucose shortly after GDM diagnosis to minimize adverse pregnancy outcomes. A real time-continuous glucose monitoring system (RT-CGMS) provides the patient with continuous information about the alterations in levels of the blood glucose. This visibility may empower the patient to modify her lifestyle and engage in therapeutic management. The aim of this study was to determine whether a single application of RT-CGMS to pregnant women shortly after GDM diagnosis is useful as an educational and motivational tool.

Methods: This study was a prospective open label randomized controlled study conducted at Maternity and Children Hospital, Medina, Saudi Arabia. A total of 130 pregnant women with GDM were randomised to either blood glucose self-monitor alone (SMBG group) (n = 62) or in addition to SMBG, patients wore a Guardian(®) REAL-Time Continuous Glucose Monitoring System (Medtronic MiniMed) once for 3-7 days, within 2 weeks of GDM diagnosis (RT-CGMS group) (n = 68). The primary outcomes were maternal glycemic control and pregnancy outcomes. Secondary outcomes were the changes in parameters of glucose variability, which includes mean sensor readings, standard deviation (SD) of blood glucose, and area under the curve for hyper and hypoglycaemia at the end of the RT-CGMS application.

Results: HbA1c, mean fasting and postprandial glucose levels were similar in both groups at the end of the pregnancy. Pregnancy outcomes were comparable. However, there was significant improvement in the parameters of glucose variability on the last day of sensor application; both mean glucose and the SD of mean glycaemia were reduced significantly; P = 0.016 and P = 0.034, respectively. The area under the curve for hyper and hypoglycaemia were improved, however, the results were not statistically significant.

Conclusion: Although a single application of RT-CGMS shortly after GDM diagnosis is helpful as an educational tool, it was not associated with improvement in glycemic control or pregnancy outcomes.

Keywords: Continuous glucose monitoring system; Gestational diabetes; Maternal glycemic control; Pregnancy outcomes; SMBG.

Figures

Fig. 1
Fig. 1
Subjects distribution
Fig. 2
Fig. 2
Parameters of glucose variability at the first and the last day of sensor application. a Sensor average glucose, b SD of the sensor average glucose, c average AUC > 7.8 mmol/L, and d average AUC < 3.9 mmol/L

References

    1. Klonoff D, Buckingham B, Christiansen J, Montori V, Tamborlane W, Vigersky R, et al. Continuous glucose monitoring: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–2979. doi: 10.1210/jc.2010-2756.
    1. Hirsch I. Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist. J Clin Endocrinol Metab. 2009;94:2232–2238. doi: 10.1210/jc.2008-2625.
    1. Deiss D, Bolinder J, Riveline J-P, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730–2732. doi: 10.2337/dc06-1134.
    1. Głowińska-Olszewska B, Tobiaszewska M, Łuczyński W, Bossowski A. Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents. Adv Med Sci. 2013;58(2):344–352. doi: 10.2478/ams-2013-0024.
    1. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor A randomized controlled trial. Diabetes Care. 2006;29(1):44–50. doi: 10.2337/diacare.29.01.06.dc05-1686.
    1. Yoo H, An H, Park S, Ryu O, Kim H, Seo J, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2008;82(1):73–79. doi: 10.1016/j.diabres.2008.06.015.
    1. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337:a1680. doi: 10.1136/bmj.a1680.
    1. Yu F, Lv L, Liang Z, Wang Y, Wen J, Lin X, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(12):4674–4682. doi: 10.1210/jc.2013-4332.
    1. Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes a randomized controlled trial. Diabetes Care. 2013;36(7):1877–1883. doi: 10.2337/dc12-2360.
    1. Association AD. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Supplement 1):S11–S61. doi: 10.2337/dc10-S011.
    1. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c–independent risk factor for diabetic complications. JAMA. 2006;295(14):1707–1708. doi: 10.1001/jama.295.14.1707.
    1. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther. 2009;11(11):717–723. doi: 10.1089/dia.2009.0077.
    1. Group JDRFCGMS The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378–1383. doi: 10.2337/dc09-0108.
    1. Jovanovič L, Savas H, Mehta M, Trujillo A, Pettitt DJ. Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care. 2011;34(1):53–54. doi: 10.2337/dc10-1455.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅